238 results


Posted on 25.06.2009

Achieving health improvements inside and outside the boardroom

A crowded room at the offices of the European Policy Center yesterday afternoon. The topic of the day is “The future of medical devices in Europe”. The distinguished panel includes Josée Hansen, Pharm. D, project leader, Priority Medical Devices/ EHT, WHO-Geneva . Ms Hansen elaborated on the project’s approach, scope and objectives. In a nutshell, […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed


Posted on 27.05.2009

Opening ceremony of Germany’s largest health policy conference, Hauptstadtkongress

Sitting in the crowded main conference hall of Berlin International Congress Center (ICC) on the opening day of Germany’s largest health policy conference, the so-called Hauptstadtkongress, I am keen to see where senior government officials see the healthcare system headed. The conference center breathes the atmosphere of a 70s sci-fi movie. I am listening to […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

Global Regulation

Posted on 15.05.2009

An Excellent 12th GHTF Conference explores answers on the future of the GHTF

Just sitting at the airport after what was an excellent Global Harmonization Task Force Conference. Well done Steve Dibert and his crew, not to mention Health Canada. Who says regulatory affairs is boring! This conference really put the moose among the pigeons! We had a truly gripping opening session from Dr. Robert Jackson, the renowned […]

By John Brennan Director Regulations and Industrial Policy

Global Regulation

Posted on 24.03.2009

The role of EMEA in future regulation: consensus amongst experts

It was with some trepidation that I placed myself in the ‘lions  den’ of the pharmaceutical industry at the annual Euromeeting of the Drug Information Association in Berlin today. Sharing a platform to discuss the evolution of medical device regulation with Mdme Georgette Lalis of the EU Commission and David Feigal, former FDA Commissioner, proved […]

By John Wilkinson Former Chief Executive of Eucomed